Search Results - "Quinn, David S"
-
1
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Published in Nature medicine (30-05-2016)Get full text
Journal Article -
2
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Published in Nature medicine (01-07-2016)“…Vaccari et al . report that SIV vaccines formulated with two different adjuvants elicit distinct immune responses and effects on SIV acquisition in rhesus…”
Get full text
Journal Article -
3
Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment
Published in Cancer research (Chicago, Ill.) (01-06-2021)“…Abstract p53 is a transcription factor that plays a central role in guarding the genomic stability of cells through cell-cycle arrest or induction of…”
Get full text
Journal Article -
4
Abstract LB061: On-target peripheral and tumor immune microenvironment modulation in patients treated with lacnotuzumab (anti-CSF1, MCS110) + spartalizumab
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Background: The CSF-1/CSF-1R (colony-stimulating factor-1) pathway plays a significant role in the tumor microenvironment via regulation of…”
Get full text
Journal Article -
5
Updated phase I study results of PHE885, a T-Charge manufactured BCMA-directed CAR-T cell therapy, for patients (pts) with r/r multiple myeloma (RRMM)
Published in Journal of clinical oncology (01-06-2023)“…8004 Background: B cell maturation antigen (BCMA) targeted CAR-T cells are approved for RRMM. Long manufacturing time and high clinical demand limit access…”
Get full text
Journal Article -
6
Phase I Study of PHE885, a Fully Human BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <2 Days Using the T-Charge TM Platform
Published in Blood (23-11-2021)“…Background: Chimeric antigen receptor (CAR)-T cells are highly effective in patients (pts) with multiple myeloma (MM), but duration of response can be limited,…”
Get full text
Journal Article -
7
Inhibition of MDM2 promotes anti-tumor responses in p53 wild-type cancer cells through their interaction with the immune and stromal microenvironment
Published in Cancer research (Chicago, Ill.) (27-01-2021)“…p53 is a transcription factor that plays a central role in guarding the genomic stability of cells through cell cycle arrest or induction of apoptosis…”
Get full text
Journal Article -
8
Erratum: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Published in Nature medicine (06-10-2016)Get full text
Journal Article -
9
Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Published in Nature medicine (01-10-2016)“…This corrects the article DOI: 10.1038/nm.4105…”
Get full text
Journal Article -
10
Adjuvant-dependent innate and adaptive immune signatures of risk of SIV sub(mac251) acquisition
Published in Nature medicine (01-07-2016)“…A recombinant vaccine containing Aventis Pasteur's canarypox vector (ALVAC)-HIV and gp120 alum decreased the risk of HIV acquisition in the RV144 vaccine…”
Get full text
Journal Article -
11
Correction: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Published in Nature medicine (2016)“…Nat. Med.; doi:10.1038/nm.4105; corrected online 16 June 2016 In the version of this article initially published online, an affiliation for Luca Schifanella…”
Get full text
Journal Article -
12
Oscillometric blood pressure: a review for clinicians
Published in Journal of the American Society of Hypertension (01-12-2014)“…Oscillometric devices for the non-invasive estimation of blood pressure (BP) have become the "clinical standard" because of training requirements for…”
Get more information
Journal Article